G-H-3 International OTCPK:GHTI Stock Report

Last Price

US$0.000001

Market Cap

US$0

7D

0%

1Y

n/a

Updated

27 May, 2024

Data

Company Financials

G-H-3 International Inc.

OTCPK:GHTI Stock Report

Market Cap: US$0

GHTI Stock Overview

Develops products for addressing factors, which cause aging and deterioration in the body. More details

GHTI fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Does not have a meaningful market cap ($0)

Has not reported any financial data

Shares are highly illiquid

My Notes

Capture your thoughts, links and company narrative

G-H-3 International Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for G-H-3 International
Historical stock prices
Current Share Price	US$0.000001
52 Week High	US$0.000001
52 Week Low	US$0.000001
Beta	0
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	-99.00%
5 Year Change	-99.00%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	GHTI	US Pharmaceuticals	US Market
7D	0%	-2.0%	-3.5%
1Y	n/a	7.6%	22.1%

Return vs Industry: Insufficient data to determine how GHTI performed against the US Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how GHTI performed against the US Market.

Price Volatility

Is GHTI's price volatile compared to industry and market?
GHTI volatility
GHTI Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	10.5%
Market Average Movement	6.3%
10% most volatile stocks in US Market	17.0%
10% least volatile stocks in US Market	3.1%

Stable Share Price: GHTI has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine GHTI's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	Flo Ternes	n/a

G-H-3 International Inc. develops products for addressing factors, which cause aging and deterioration in the body. Its product, G-H-3-Plus is a comprehensive protocol that promotes anti-aging, treat chronic disease, and improve health and vitality. The G-H-3-Plus protocol includes a combination of intravenous treatment, intramuscular injections, prescriptions, vitamins, and skin care products.

G-H-3 International Inc. Fundamentals Summary

How do G-H-3 International's earnings and revenue compare to its market cap?
GHTI fundamental statistics
Market cap	n/a
Earnings (TTM)	US$0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is GHTI overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GHTI income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	US$0
Earnings	US$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did GHTI perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/05/27 02:38
End of Day Share Price	2024/02/28 00:00
Earnings	N/A
Annual Earnings	N/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

G-H-3 International Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution